Nasal Cavity Articles & Analysis: Older
10 news found
“Orgenesis, through its newly formed POCare services subsidiary, has commenced clinical grade production, in collaboration with Hospital Infantil Universitario Niño Jesús in Madrid for the supply of clinical-grade batches of the cell-based product intended for intravenous administration. The nasal delivery of the cell-based product has only been tested in ...
Clínica Universidad de Navarra has completed a randomised controlled study of Ondine Biomedical’s nasal photodisinfection technology in fully vaccinated COVID-19 patients with early symptoms of COVID-19. “Top-line results from this clinical trial suggest that nasal photodisinfection treatment rapidly and substantially suppresses SARS-CoV-2 ...
Liquid dosage forms are administered by oral and parenteral (injection, inhalation, ophthalmology, ear canal, nasal cavity and topical) routes. Oral liquids are non-sterile, while liquids administered by parenteral routes are available in sterile and non-sterile formulations,” says a senior scientist from CD Formulation. ...
This is done by accessing the most permeable part of the BBB — the olfactory mucosa at the top of the nasal cavity — where nerves penetrate to convey signals to the brain. ...
Liquid dosage forms are administered by oral and parenteral (injection, inhalation, ophthalmology, ear canal, nasal cavity and topical) routes. Oral liquids are non-sterile, while liquids administered by parenteral routes are available in sterile and non-sterile formulations,” says a senior scientist from CD Formulation. ...
Data from a completed Phase 1a study showed a 10^6 PFU dose of MV-012-968 was safe and well-tolerated among healthy RSV sero-low adults and resulted in no detectable nasal shedding of infectious vaccine virus, while inducing RSV-specific mucosal IgA in the majority of vaccine recipients, despite pre-existing immunity to RSV (ClinicalTrials.gov Identifier NCT04227210). ...
Intranasal vaccines generate both mucosal (IgA) antibodies in the nasal cavity and antibodies that circulate in the blood (serum). In contrast, injected vaccines typically induce circulating but not mucosal antibodies. ...
” The device, which can cut the usual placement procedure time in half, harnesses the power of electromagnetic mapping to guide medical-support staff in placing the tube from the nasal cavity down the esophagus, and all the way through to the small intestine, the anatomical location where nutrients are absorbed by the body. ...
This speculum is used to view the nasal cavity for nasal examinations and procedures, like foreign body removal and nasal packing. It has two dexterous flat handles that are used to change the distance between the two coned blades, and therefore, dilate the nasal opening. The Allis Intestinal and Tissue grasping ...
"Neurent Medical has based its rhinitis device on its extensive research on neuronal activity in the nasal cavity and the cellular makeup of the nasal mucosa. These guiding principles have enabled the product to stand out as a low-powered RF treatment that targets the autonomic supply to the nasal turbinates, positively impacting ...